| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.345 | 0.012 | 0.359 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.359 0.01 CHEMBL3526475 | CHEMBL3526475 | |
| 0.305 | 0.028 | 0.326 | Anticoagulant | 0.326 0.024 CHEMBL3526475 | CHEMBL3526475 | |
| 0.279 | 0.002 | 0.279 | Sodium/hydrogen exchanger inhibitor | 0.216 0.002 CHEMBL3526475 | ||
| 0.31 | 0.034 | 0.31 | Ca(v)3.3 blocker | 0.257 0.09 CHEMBL3526475 | ||
| 0.262 | 0.016 | 0.262 | Sodium channel blocker | 0.255 0.017 CHEMBL3526475 | ||
| 0.342 | 0.099 | 0.342 | MAP kinase kinase 6 inhibitor | 0.248 0.193 CHEMBL3526475 | ||
| 0.308 | 0.068 | 0.326 | Interleukin 2 agonist | 0.326 0.057 CHEMBL3526475 | CHEMBL3526475 | |
| 0.249 | 0.021 | 0.249 | Neurotensin receptor agonist | 0.209 0.031 CHEMBL3526475 | ||
| 0.22 | 0.01 | 0.22 | Nav1.5 sodium channel blocker | 0.199 0.013 CHEMBL3526475 | ||
| 0.196 | 0.031 | 0.196 | Sodium channel (voltage-gated) blocker | 0.186 0.035 CHEMBL3526475 | ||
| 0.254 | 0.092 | 0.315 | Insulysin inhibitor | 0.315 0.05 CHEMBL3526475 | CHEMBL3526475 | |
| 0.194 | 0.035 | 0.194 | Hemostatic | 0.191 0.036 CHEMBL3526475 | ||
| 0.338 | 0.182 | 0.338 | Antiinflammatory | 0.304 0.211 CHEMBL3526475 | ||
| 0.187 | 0.039 | 0.187 | Nav1.2 sodium channel blocker | 0.186 0.04 CHEMBL3526475 | ||
| 0.155 | 0.016 | 0.155 | Interleukin 2 antagonist | 0.143 0.022 CHEMBL3526475 | ||
| 0.145 | 0.008 | 0.145 | Urokinase inhibitor | 0.144 0.008 CHEMBL3526475 | ||
| 0.223 | 0.086 | 0.266 | Platelet antagonist | 0.266 0.066 CHEMBL3526475 | CHEMBL3526475 | |
| 0.163 | 0.029 | 0.187 | 5 Hydroxytryptamine 3A agonist | 0.187 0.019 CHEMBL3526475 | CHEMBL3526475 | |
| 0.141 | 0.01 | 0.141 | 5 Hydroxytryptamine 3 antagonist | 0.101 0.017 CHEMBL3526475 | ||
| 0.227 | 0.098 | 0.272 | Cardiotonic | 0.272 0.069 CHEMBL3526475 | CHEMBL3526475 | |
| 0.146 | 0.02 | 0.146 | Factor V inhibitor | 0.145 0.021 CHEMBL3526475 | ||
| 0.244 | 0.12 | 0.244 | Immunomodulator | 0.204 0.16 CHEMBL3526475 | ||
| 0.21 | 0.096 | 0.21 | MAP kinase kinase 3 inhibitor | |||
| 0.154 | 0.043 | 0.154 | Cathepsin H inhibitor | 0.134 0.06 CHEMBL3526475 | ||
| 0.112 | 0.007 | 0.112 | Smo receptor antagonist | 0.062 0.018 CHEMBL3526475 | ||
| 0.124 | 0.021 | 0.124 | Neuropeptide agonist | 0.108 0.025 CHEMBL3526475 | ||
| 0.153 | 0.05 | 0.153 | Nav1.6 sodium channel blocker | 0.126 0.088 CHEMBL3526475 | ||
| 0.207 | 0.11 | 0.207 | Superoxide dismutase inhibitor | |||
| 0.165 | 0.071 | 0.165 | Thrombolytic | 0.161 0.074 CHEMBL3526475 | ||
| 0.134 | 0.042 | 0.142 | Nav1.4 sodium channel blocker | 0.142 0.037 CHEMBL3526475 | CHEMBL3526475 | |
| 0.095 | 0.018 | 0.111 | Plasminogen activator inhibitor | 0.111 0.013 CHEMBL3526475 | CHEMBL3526475 | |
| 0.084 | 0.012 | 0.084 | Cyclin A1 inhibitor | 0.083 0.013 CHEMBL3526475 | ||
| 0.171 | 0.102 | 0.171 | Interleukin antagonist | 0.169 0.104 CHEMBL3526475 | ||
| 0.076 | 0.008 | 0.076 | Histamine H2 receptor agonist | 0.071 0.01 CHEMBL3526475 | ||
| 0.09 | 0.023 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.064 CHEMBL3526475 | ||
| 0.101 | 0.036 | 0.101 | Factor XII inhibitor | 0.098 0.039 CHEMBL3526475 | ||
| 0.212 | 0.156 | 0.212 | Angiogenesis inhibitor | 0.194 0.176 CHEMBL3526475 | ||
| 0.113 | 0.061 | 0.113 | Activin receptor-like kinase 4 inhibitor | |||
| 0.068 | 0.018 | 0.068 | Complement C3a chemotactic receptor antagonist | 0.064 0.02 CHEMBL3526475 | ||
| 0.06 | 0.012 | 0.095 | Factor XIa inhibitor | 0.095 0.006 CHEMBL3526475 | CHEMBL3526475 | |
| 0.084 | 0.037 | 0.084 | Thrombin inhibitor | 0.082 0.039 CHEMBL3526475 | ||
| 0.066 | 0.02 | 0.074 | Kallikrein inhibitor | 0.074 0.017 CHEMBL3526475 | CHEMBL3526475 | |
| 0.093 | 0.052 | 0.093 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.078 0.074 CHEMBL3526475 | ||
| 0.072 | 0.032 | 0.075 | Trypsin inhibitor | 0.075 0.03 CHEMBL3526475 | CHEMBL3526475 | |
| 0.121 | 0.084 | 0.121 | Cyclin-dependent kinase 7 inhibitor | 0.102 0.098 CHEMBL3526475 | ||
| 0.051 | 0.015 | 0.06 | Vascular adhesion protein 1 inhibitor | 0.06 0.009 CHEMBL3526475 | CHEMBL3526475 | |
| 0.047 | 0.013 | 0.054 | Plasma kallikrein inhibitor | 0.054 0.01 CHEMBL3526475 | CHEMBL3526475 | |
| 0.068 | 0.037 | 0.068 | CXC chemokine 4 receptor antagonist | |||
| 0.05 | 0.022 | 0.056 | Factor X inhibitor | 0.056 0.019 CHEMBL3526475 | CHEMBL3526475 | |
| 0.048 | 0.025 | 0.049 | Parathyroid hormone antagonist | 0.049 0.023 CHEMBL3526475 | CHEMBL3526475 | |
| 0.065 | 0.041 | 0.065 | 5 Hydroxytryptamine 3 agonist | |||
| 0.122 | 0.1 | 0.122 | Farnesoid X receptor antagonist | |||
| 0.063 | 0.043 | 0.063 | Protease activated receptor antagonist | |||
| 0.089 | 0.069 | 0.105 | CDK2/cyclin A inhibitor | 0.105 0.054 CHEMBL3526475 | CHEMBL3526475 | |
| 0.02 | 0.006 | 0.02 | Tryptophan hydroxylase 1 inhibitor | 0.019 0.009 CHEMBL3526475 | ||
| 0.044 | 0.03 | 0.044 | Histamine H1 receptor agonist | |||
| 0.123 | 0.11 | 0.123 | Thiol protease inhibitor | |||
| 0.045 | 0.032 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.043 0.037 CHEMBL3526475 | ||
| 0.054 | 0.043 | 0.055 | Kallikrein 1 inhibitor | 0.055 0.042 CHEMBL3526475 | CHEMBL3526475 | |
| 0.034 | 0.024 | 0.049 | Factor XI inhibitor | 0.049 0.01 CHEMBL3526475 | CHEMBL3526475 | |
| 0.044 | 0.035 | 0.044 | Protease activated receptor 1 antagonist | |||
| 0.045 | 0.035 | 0.05 | Melanocortin antagonist | 0.05 0.029 CHEMBL3526475 | CHEMBL3526475 | |
| 0.057 | 0.047 | 0.057 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.039 | 0.031 | 0.046 | Acid-sensing ion channel blocker | 0.046 0.02 CHEMBL3526475 | CHEMBL3526475 | |
| 0.039 | 0.033 | 0.043 | Melanocortin 4 antagonist | 0.043 0.028 CHEMBL3526475 | CHEMBL3526475 | |
| 0.049 | 0.045 | 0.049 | Maillard reaction inhibitor | |||
| 0.047 | 0.045 | 0.047 | Histamine agonist | |||
| 0.039 | 0.038 | 0.039 | Neurotensin receptor antagonist | |||
| 0.033 | 0.032 | 0.033 | Diamine oxidase inhibitor | |||
| 0.082 | 0.081 | 0.082 | Protein kinase C zeta inhibitor | |||
| 0.077 | 0.078 | 0.082 | Falcipain inhibitor | 0.082 0.071 CHEMBL3526475 | CHEMBL3526475 | |
| 0.042 | 0.045 | 0.043 | Benzodiazepine inverse agonist | 0.043 0.041 CHEMBL3526475 | CHEMBL3526475 | |
| 0.073 | 0.078 | 0.079 | Falcipain 2 inhibitor | 0.079 0.071 CHEMBL3526475 | CHEMBL3526475 | |
| 0.131 | 0.137 | 0.16 | Lipocortins synthesis antagonist | 0.16 0.092 CHEMBL3526475 | CHEMBL3526475 | |
| 0.082 | 0.097 | 0.092 | Cyclin-dependent kinase 2 inhibitor | 0.092 0.079 CHEMBL3526475 | CHEMBL3526475 | |
| 0.112 | 0.134 | 0.121 | Growth hormone agonist | 0.121 0.12 CHEMBL3526475 | CHEMBL3526475 | |
| 0.191 | 0.213 | 0.248 | Toll-Like receptor agonist | 0.248 0.15 CHEMBL3526475 | CHEMBL3526475 | |
| 0.188 | 0.217 | 0.242 | Toll-Like receptor 7 agonist | 0.242 0.154 CHEMBL3526475 | CHEMBL3526475 | |
| 0.249 | 0.289 | 0.286 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.286 0.232 CHEMBL3526475 | CHEMBL3526475 | |
| 0.073 | 0.119 | 0.087 | Nav1.1 sodium channel blocker | 0.087 0.085 CHEMBL3526475 | CHEMBL3526475 | |
| 0.125 | 0.177 | 0.173 | Death-associated protein kinase 2 inhibitor | 0.173 0.064 CHEMBL3526475 | CHEMBL3526475 | |
| 0.037 | 0.093 | 0.05 | Sodium/calcium exchanger inhibitor | 0.05 0.034 CHEMBL3526475 | CHEMBL3526475 | |
| 0.086 | 0.184 | 0.139 | Psychostimulant | 0.139 0.126 CHEMBL3526475 | CHEMBL3526475 | |
| 0.104 | 0.226 | 0.149 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.149 0.146 CHEMBL3526475 | CHEMBL3526475 | |
| 0.135 | 0.273 | 0.184 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.184 0.177 CHEMBL3526475 | CHEMBL3526475 | |
| 0.019 | 0.159 | 0.074 | NMDA 2 receptor antagonist | 0.074 0.048 CHEMBL3526475 | CHEMBL3526475 | |
| 0.107 | 0.304 | 0.192 | Gastrin inhibitor | 0.192 0.161 CHEMBL3526475 | CHEMBL3526475 | |
| 0.012 | 0.425 | 0.077 | Nicotinic acid receptor 1 agonist | 0.077 0.011 CHEMBL3526475 | CHEMBL3526475 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |